(Q51157618)

31 March 2018

title

Human teratogens: update 2010. (English)

1 reference

31 March 2018

author name string

Lewis B Holmes

series ordinal

1

1 reference

31 March 2018

publication date

6 January 2011

1 reference

31 March 2018

Birth Defects Research Part A: Clinical and Molecular Teratology

published in

1 reference

31 March 2018

volume

91

1 reference

31 March 2018

issue

1

1 reference

31 March 2018

page(s)

1-7

1 reference

31 March 2018

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Clusters of anophthalmia. No link with benomyl in Italy...

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Effects on toes from prenatal exposure to anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Intracytoplasmic sperm injection may increase the risk of imprinting defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Maternal and fetal sequelae of anticoagulation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Risks of anticoagulant therapy in pregnant women with artificial heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Quantitative analysis of associations between birth defects and suspected human teratogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Retinoic acid embryopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Maternal exposure to statins and risk for birth defects: a case-series approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

High prevalence of muscular ventricular septal defect in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Baby care products: possible sources of infant phthalate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Decrease in anogenital distance among male infants with prenatal phthalate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Is this drug safe in pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Present status of drugs as teratogens in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20748

21 January 2018

Identifiers

DOI

10.1002/BDRA.20748

1 reference

31 March 2018

1 reference

31 March 2018